Infliximab- and Immunosuppressant-Resistant Crohn’s Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone

Infliximab- and Immunosuppressant-Resistant Crohn’s Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone

Activated granulocytes, monocytes, and platelets appear to be closely involved in active Crohn’s disease (CD). Adsorptive granulocyte apheresis (GCAP) is a new treatment for inflammatory bowel disease. GCAP was used to treat a 23-year-old female patient with CD resistant to both infliximab (IFX) and...

Full description

Bibliographic Details
Main Authors: Munenori Itagaki, Masayuki Saruta, Toshio Iinuma, Seiji Arihiro, Tomohiro Kato, Hisao Tajiri
Format: Article
Language:English
Published: Karger Publishers 2012-02-01
Series:Case Reports in Gastroenterology
Subjects:
Adsorptive granulocyte apheresis
Infliximab
Prednisolone
Azathioprine
Crohn’s disease
Online Access:http://www.karger.com/Article/FullText/334428

Internet

http://www.karger.com/Article/FullText/334428

Similar Items